Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on November 21, 2007
Cardiovascular Research, doi:10.1093/cvr/cvm077
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
77/3/525    most recent
cvm077v2
cvm077v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jiang, S.
Right arrow Articles by Muhammad, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, S.
Right arrow Articles by Muhammad, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair

Shujia Jiang, MD, Husnain Kh Haider, MPharm PhD, Niagara M Idris, MSc, Lu G, PhD and Ashraf Muhammad, PhD

Department of Pathology and Laboratory Medicine, 231-Albert Sabin Way, University of Cincinnati, Ohio-45267-0529

For correspondence: Prof Muhammad Ashraf Department of Pathology and Laboratory of Medicine, 231-Albert Sabin Way, University of Cincinnati Cincinnati, Ohio-45267-0529 Muhammad.ashraf{at}uc.edu Phone: 513-558-0145 Fax: 513-558-0807

Aim: We have previously shown that transplantation of mesenchymal stem cells (MSCs) co-overexpressing angiopoietin-1 (Ang-1) and Akt prevented cell apoptosis, enhanced angiogenesis and improved left ventricular heart function. The present study was designed to determine the persistence of therapeutic benefits on longer-term basis.

Methods and Results: Acute myocardial infarction model was developed in 30 young female Fischer-344 rats by permanent ligation of the left anterior descending coronary artery. The animals were grouped (n=10) to receive 70 µl Dulbecco's modified Eagle's medium (DMEM) without cells (DMEM group-1) or containing 3x106 non-transduced male MSCs (MSC group-2) or transduced MSCs co-overexpressing Ang-1 and Akt (MAA group-3). The injections were carried out intramyocardially in the free wall of left ventricle at multiple sites. Three months after cell transplantation, real-time PCR for the rat sry-gene, confocal imaging and immunohistochemical studies revealed the extensive survival and myogenic differentiation of the PKH67-labeled cell graft. Blood vessel density was significantly higher in the MAA group (p<0.05) at 3 months as compared with the other groups. Blood vessel maturation index as determined by double fluorescent immunostaining for vWFactor VIII and smooth muscle actin showed that most of the newly formed vessels matured to develop a smooth muscle covering in MAA group. Sonographic assessment of heart function showed that heart function deteriorated in the DMEM group whereas the functional benefits were stable over a period of 3 months following transplantation of transfected cells.

Conclusion: Engraftment of genetically modified MSCs co-overexpressing Ang-1 and Akt produced long-term histological and functional benefits in an infarcted heart.

Time for primary review: 25


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
B. Russell and J. M. Collins
Hearty slices to plan for future health
Cardiovasc Res, February 1, 2009; 81(2): 235 - 236.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J.-X. Chen and A. Stinnett
Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1606 - 1613.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.